New drug curing COVID when it reaches cytokine storm? Zero media coverage?
Dr. Chris Recknor, a Gainesville internist who runs one of the six sites for the leronlimab clinical trial, is also a COVID-19 survivor.
He first got sick in April. His physician at the hospital obtained "compassionate use" permission from the Food and Drug Administration to prescribe leronlimab.
Researchers think that the drug may work by calming the aggressive immune response called the "cytokine storm," which occurs in ill COVID-19 patients.
Recknor said he felt better within two days after getting the medication and has fully recovered.
https://medicalxpress.com/news/2020-06-covid-symptoms-linger-weeks-months.html